Literature DB >> 11704382

Leukocyte mitochondria depolarization and apoptosis in advanced heart failure: clinical correlations and effect of therapy.

C W Kong1, T G Hsu, F J Lu, W L Chan, K Tsai.   

Abstract

OBJECTIVES: The purpose of this study was to examine the changes in leukocyte mitochondrial transmembrane potential (MTP) and its association with apoptosis in congestive heart failure (CHF).
BACKGROUND: Congestive heart failure is a heterogeneous syndrome with multiple hemodynamic, neuroendocrine and immune abnormalities. Although edematous CHF may be associated with endotoxemia and increased cytokine production, peripheral blood leukocyte functions in advanced CHF remain unclear.
METHODS: Thirty patients with acute decompensated CHF (mean age [+/- SEM] 74.9 +/- 3.1 years) and 20 healthy controls underwent determination of MTP, intracellular oxidants and apoptosis in three subsets of peripheral blood leukocytes. The measurements were repeated after the time of recompensation.
RESULTS: Patients with acute CHF showed marked MTP reduction and increased intracellular oxidant formation in three subsets of leukocytes upon entry into the study. These changes were more prominent in patients with peripheral edema. The decline in MTP was correlated with the severity of the peripheral edema and plasma concentration of cortisol, nitrogen metabolites and tumor necrosis factor-alpha (p < 0.01). After clinical stabilization, MTP gradually recovered. Leukocytes underwent increased propensity of apoptosis one week after the time of recompensation.
CONCLUSIONS: The mitochondrial depolarization and apoptosis of leukocytes in decompensated heart failure suggest that CHF is associated with severity-dependent impairments in leukocyte function. Accentuated hormonal and cytokine abnormalities and increased circulating oxidants may contribute to these changes. Early and aggressive management of advanced heart failure is helpful in the recovery of these immune abnormalities.

Entities:  

Mesh:

Year:  2001        PMID: 11704382     DOI: 10.1016/s0735-1097(01)01601-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease.

Authors:  Qingmin Ruan; Adam J Harrington; Kim A Caldwell; Guy A Caldwell; David G Standaert
Journal:  Neurobiol Dis       Date:  2009-10-20       Impact factor: 5.996

2.  Mitochondrial respiratory dysfunctions of blood mononuclear cells link with cardiac disturbance in patients with early-stage heart failure.

Authors:  Peng Li; Bin Wang; Fang Sun; Yingsha Li; Qiang Li; Hongmei Lang; Zhigang Zhao; Peng Gao; Yu Zhao; Qianhui Shang; Daoyan Liu; Zhiming Zhu
Journal:  Sci Rep       Date:  2015-05-28       Impact factor: 4.379

Review 3.  New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases.

Authors:  Marianne Riou; Abrar Alfatni; Anne-Laure Charles; Emmanuel Andrès; Cristina Pistea; Anne Charloux; Bernard Geny
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

4.  Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes.

Authors:  Roberta Coluccia; Salvatore Raffa; Danilo Ranieri; Andrea Micaloni; Sabatino Valente; Gerardo Salerno; Cristina Scrofani; Marco Testa; Giovanna Gallo; Erika Pagannone; Maria Rosaria Torrisi; Massimo Volpe; Speranza Rubattu
Journal:  Oncotarget       Date:  2018-10-12

Review 5.  Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art.

Authors:  Speranza Rubattu; Maurizio Forte; Salvatore Raffa
Journal:  Oxid Med Cell Longev       Date:  2019-10-15       Impact factor: 6.543

Review 6.  Peripheral Blood Mononuclear Cells and Platelets Mitochondrial Dysfunction, Oxidative Stress, and Circulating mtDNA in Cardiovascular Diseases.

Authors:  Abrar Alfatni; Marianne Riou; Anne-Laure Charles; Alain Meyer; Cindy Barnig; Emmanuel Andres; Anne Lejay; Samy Talha; Bernard Geny
Journal:  J Clin Med       Date:  2020-01-22       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.